Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males

European Journal of Endocrinology

Volumn 135, Issue 5, 1996, Pages 548-552

  Colao, Annamaria ^a   De Rosa, Michele ^a   Sarnacchiaro, Francesca ^a   Di Sarno, Antonella ^a   Landi, Maria Luisa ^a   Iervolino, Emilia ^a   Zarrilli, Stefano ^a   Merola, Bartolomeo ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; QUINAGOLIDE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; GONAD FUNCTION; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; SEXUAL FUNCTION; VOMITING;

EID: 0029905682     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350548     Document Type: Article

References (33)

1. Ambrosi B, Gaggini M, Moriondo P, Faglia G. Prolactin and sexual function [letter]. JAMA 1980;244(23):2608
2. Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Prolactin-secreting tumors and hypogonadism in 22 men. N Engl J Med 1978;299:847-52
3. Segal S, Yaffe H, Laufer N, Ben-David M. Male hyperprolactinemia: effects in fertility. Fertil Steril 1979;32:556-61
4. Gonzales GF, Garcia-Hjarles M, Velasquez G. Hyperprolactinaemia and hyperserotoninaemia: their relationship to seminal quality. Andrologia 1992;24:95-100
5. Thorner MO, McNeilly AS, Hagan C, Besser GM. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J 1974;2:419-22
6. Ambrosi B, Bara R, Travaglini P, et al. Short communication: study of the effects of bromocriptine on sexual impotence. Clin Endocrinol 1977;7:417-21
7. Hovatta O, Koskimies AI, Ranta T, Stenman UH, Seppala M. Bromocriptine treatment of oligospermia a double blind study. Clin Endocrinol 1979;11:377-82
8. Vance M, Evans W, Thorner M. Bromocriptine. Ann Intern Med 1984;100:78-91
9. Chiodini P, Liuzzi A, Cozzi R, et al. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. J Clin Endocrinol Metab 1981;53:737-43
10. Webster J, Piscitelli G, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994;331:904-9
11. Grossman A, Bouloux PMG, Loneragan R, Rees LH, Wass JAH, Besser GM. Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinemia. Clin Endocrinol 1985;22:611-6
12. Ferrari C, Mattel A, Melis GB, et al. Cabergoline: long-acting oral treatment of hyperprolactinemia disorders. J Clin Endocrinol Metab 1989;69:1201-6
13. Schettini G, Lombardi G, Merola B, et al. Rapid and long-lasting suppression on prolactin secretion and shrinkage of prolactinomas with improved tolerability after injection of long-action repeatable form of bromocriptine (Parlodel LAR). Clin Endocrinol 1990;33:161-9
14. Merola B, Colao A, Caruso E, et al. Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia. J Endocrinol Invest 1992;15:173-6
15. Khalfallah Y, Clustrat B, Grochowicki M, et al. Effects of a new prolactin inhibitor, CV 205-502, in the treatment of human macroprolactinomas. J Clin Endocrinol Metab 1990;71:354-9
16. Brue T, Pellegrini I, Gunz G, et al. Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine. J Clin Endocrinol Metab 1992;74:577-84
17. Colao A, Merola B, Sarnacchiaro F, et al. Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas. Horm Res 1995;44:222-8
18. WHO Laboratory manual for the examination of human semen and semen-cervical mucus interaction. Cambridge: Cambridge University Press, 1993
19. De Rosa M, Amalfi B, Mennitti M, Zarrilli S, Lombardi G. The usefulness of new tests in the evaluation of the ejaculate. In: Colpi GM, Pozza D, editors. Diagnosing male infertility. Prog Reprod Biol Med 1992;15:19-26
20. Eliasson R, Treichi L. Supravital staining of spermatozoa. Fertil Steril 1971;22:134-8
21. Jeyendran RS, van der Ven HH, Perez-Pelaez M, Carbo BG, Zaneveld LJD. Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. J Reprod Fertil 1984;70:219-28
22. Moghissi KS, Segal S, Meinhold D, Aronow SJ. In vitro sperm cervical mucus penetration: studies in human and bovine cervical mucus. Fertil Steril 1982;37:823-7
23. Bartke AJ. Effects of prolactin and luteinizing hormone on the cholesterol stores in the mouse testis. J Endocr 1971;49:317-20
24. 14C)acetate into testosterone and cholesterol by testes from hypophysectomized rats in vitro. J Endocr 1972;53:223-6
25. Park SK, Keenan MW, Selmanoff M. Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats. Neuroendocrinology 1993;58(4):448-53
26. Molitch ME, Rebar RW, Barsano CP. Effect of human prolactin administration on gonadotropin and thyrotropin secretion in normal men. J Endocrinol Invest 1993;16(8):559-64
27. Rubin RT, Poland RE, Sobel I. Effects of prolactin and prolactin plus luteinizing hormone on plasma testosterone levels in normal adult men. J Clin Endocrinol Metab 1978;47:447-52
28. Bonnet HG, Dahlen HG, Wuttke W, Schneider HPG. Hyperprolactinemic anovulatory syndrome. J Clin Endocrinol Metab 1976;42:132-43
29. Magrini G, Ebiner JR, Burckhardt P, Felber JP. Study of the relationship between plasma prolactin levels and androgen metabolism in man. J Clin Endocrinol Metab 1976;43:944-7
30. Bouchard P, Lagoguey M, Brailly S, Schaison G. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab 1985;60:258-62
31. Cheung CY. Prolactin suppresses LH secretion and pituitary responsiveness to LHRH by a direct action at the anterior pituitary. Endocrinology 1983;113:632-8
32. Colao A, Merola B, Di Sarno A, et al. Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients. Gynecol Endocrinol 1995;9:15-21
33. Winters SJ, Troen P. Altered pulsatile secretion of luteinizing hormone in hypogonadal men with hyperprolactinaemia. Clin Endocrinol 1984;21:257-63